rs117964204

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_018896.5(CACNA1G):​c.4760-640C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0178 in 152,330 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.018 ( 46 hom., cov: 33)

Consequence

CACNA1G
NM_018896.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0120

Publications

16 publications found
Variant links:
Genes affected
CACNA1G (HGNC:1394): (calcium voltage-gated channel subunit alpha1 G) Voltage-sensitive calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division, and cell death. This gene encodes a T-type, low-voltage activated calcium channel. The T-type channels generate currents that are both transient, owing to fast inactivation, and tiny, owing to small conductance. T-type channels are thought to be involved in pacemaker activity, low-threshold calcium spikes, neuronal oscillations and resonance, and rebound burst firing. Many alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Sep 2011]
CACNA1G Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, PanelApp Australia, Ambry Genetics
  • spinocerebellar ataxia type 42
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Illumina
  • intellectual disability
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0178 (2704/152330) while in subpopulation NFE AF = 0.0286 (1949/68032). AF 95% confidence interval is 0.0276. There are 46 homozygotes in GnomAd4. There are 1291 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 46 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018896.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
NM_018896.5
MANE Select
c.4760-640C>T
intron
N/ANP_061496.2
CACNA1G
NM_198377.3
c.4727-640C>T
intron
N/ANP_938191.2
CACNA1G
NM_198396.3
c.4658-640C>T
intron
N/ANP_938406.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
ENST00000359106.10
TSL:1 MANE Select
c.4760-640C>T
intron
N/AENSP00000352011.5
CACNA1G
ENST00000507336.5
TSL:1
c.4727-640C>T
intron
N/AENSP00000420918.1
CACNA1G
ENST00000507510.6
TSL:1
c.4760-640C>T
intron
N/AENSP00000423112.2

Frequencies

GnomAD3 genomes
AF:
0.0178
AC:
2705
AN:
152212
Hom.:
46
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00410
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.00726
Gnomad ASJ
AF:
0.00692
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.0379
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0286
Gnomad OTH
AF:
0.00860
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0178
AC:
2704
AN:
152330
Hom.:
46
Cov.:
33
AF XY:
0.0173
AC XY:
1291
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00406
AC:
169
AN:
41584
American (AMR)
AF:
0.00725
AC:
111
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00692
AC:
24
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4826
European-Finnish (FIN)
AF:
0.0379
AC:
403
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0286
AC:
1949
AN:
68032
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
134
268
402
536
670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0247
Hom.:
64
Bravo
AF:
0.0147
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
16
DANN
Benign
0.69
PhyloP100
-0.012
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117964204; hg19: chr17-48692082; API